Novonesis A/s Class B · OMXCOP:NSIS_B

Novonesis A/s Class B — Novozymes — FY2018 Earnings Presentation

14 slides from Novonesis A/s Class B's earnings presentation, Jan 24, 2019

  1. Slide 1: Conference call 12M 2018

    Conference call 12M 2018 January 24, 2019

  2. Slide 2: Highlights

    Highlights Satisfactory 2018 performance Key financials February 2018 2018 (DKKbn) Outlook Realized • Financial guidance parameters met as set out at the beginning of 2018 Sales growth, organic 4-6% 4% • Bioenergy strong; solid performance in Food & Beverages; growth in Agriculture & Feed; Household

  3. Slide 3: Organic sales growth by geography

    Organic sales growth by geography North America 34%of sales Europe, the Middle East & Africa 36% of sales 12M 2018 y/y: 5% 12M 2018 y/y: 1% Q4 y/y: 3% Q4 y/y: 1% Developed Emerging 65% (12M 2018: 3% y/y) 35% 10% 20% (12M 2018: 5% y/y) Latin America Asia Pacific of sales of sales 12M 2018 y/y: 6% 12M

  4. Slide 4: Household Care

    Household Care 32% of sales Flat performance in 2018 FY organic sales growth 4% • Organic growth 12M 2018 0% y/y; Q4 2018 1% y/y • Weakness in the Middle East due to economic distress and trade sanctions • Global customers continued cost optimization – in line with expectations • Sales to regional c

  5. Slide 5: Food & Beverages

    Food & Beverages 29% of sales FY organic sales growth Solid and wide-ranging growth 9% • Organic growth 12M 2018 +5% y/y; Q4 2018 +7% y/y • Broad-based growth; especially strong in food & nutrition and beverages • Strong growth in oils & fats 5% 5% • Baking performed well in Asia Pacific but hampere

  6. Slide 6: Bioenergy

    Bioenergy 19% of sales Continued strong momentum for biofuels FY organic sales growth 19% • Organic growth 12M 2018 +12% y/y; Q4 2018 +5% y/y • New yeast technology well received; second product, Innova ® Lift, 11% 12% launched in Q4 • Good growth across regions for conventional biofuels • US and gl

  7. Slide 7: Agriculture & Feed

    Agriculture & Feed 14% of sales Mixed year with strong growth in BioAg FY organic sales growth • Organic growth 12M 2018 +3% y/y; Q4 2018 -3% y/y 19% • Strong BioAg performance driven by Acceleron® B-360 • Sales to animal feed challenged; difficult market conditions in Latin America 7% 5% • Alterion

  8. Slide 8: R&D update – priority innovation platforms

    R&D update – priority innovation platforms Freshness solutions for laundry detergents Arrows denote progress over the past 12 months. 8

  9. Slide 9: Two exciting collaborations

    Two exciting collaborations Making every drop count BioSec® - our first product from the water platform launched in December Leveraging technology that partly originates from our biomass conversion research The Copenhagen wastewater treatment facility BIOFOS is the first end-user applying our enzyma

  10. Slide 10: Financials – 2018

    Financials – 2018 Satisfactory 2018 Key financials 2017 February 2018 2018 • Initial 2018 financial outlook parameters met (DKKbn) Realized Outlook Realized • Organic sales growth at +4% • Middle East and Feed were main negative surprises Sales growth, organic 4% 4-6% 4% • Reported EBIT margin at 28

  11. Slide 11: Financials – 2019 outlook

    Financials – 2019 outlook 3-6% organic sales growth and solid earnings • Organic sales growth guidance of 3-6%. Key financials 2018 2019 Currencies add ~1pp in reported Danish kroner (DKKbn) realized outlook • Growth expected in all businesses as well as from both Sales growth, organic 4% 3-6% emerg

  12. Slide 12: Summary

    Summary Summary Satisfactory 2018 results – financial outlook met Satisfactory 2018 results • • Satisfactory Satisfactoryresults; guidance results; parameters guidance from from beginning of 2018 met beginning of 2018 met • Challenging Middle Eastern markets were the main unexpected drag on • Challe

  13. Slide 13: Our business is about turning amazing science into sustainable biological answers

    Our business is about turning amazing science into sustainable biological answers in a growing world 6,500 3rd 48% 88 million More than 6,500 active and In 2018, Science Magazine Market leader in industrial In 2018, our customers pending patents ranked Novozymes the enzymes with an estimated avoided

  14. Slide 14: Forward-looking statements

    Forward-looking statements This presentation and its related comments contain forward-looking statements, including statements about future events, future financial performance, plans, strategies and expectations. Forward-looking statements are associated with words such as, but not limited to, "bel

Novozymes — FY2018 Earnings Presentation on 6ix